Literature DB >> 16684492

Recent insights into cardiac hypertrophy and left ventricular remodeling.

Risto Kerkela1, Thomas Force.   

Abstract

Cardiac hypertrophy is a compensatory mechanism of the heart to maintain cardiac output under stresses that compromise cardiac function. Mechanical stretch and neurohumoral factors induce changes in intracellular signaling pathways resulting in increased protein synthesis and activation of specific genes promoting cardiac growth, eventually leading to left ventricular remodeling and cardiac dysfunction. The remodeling process results from alterations in cardiac myocytes as well as the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684492     DOI: 10.1007/s11897-006-0026-6

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  52 in total

1.  Complete nucleotide sequence and structural organization of rat cardiac troponin T gene. A single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing.

Authors:  J P Jin; Q Q Huang; H I Yeh; J J Lin
Journal:  J Mol Biol       Date:  1992-10-20       Impact factor: 5.469

2.  Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

Authors:  D Wang; P S Chang; Z Wang; L Sutherland; J A Richardson; E Small; P A Krieg; E N Olson
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

3.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Shuxun Ren; E Rene Rodriguez; Barbara Tavazzi; Giuseppe Lazzarino; Nazareno Paolocci; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators.

Authors:  N S Belaguli; J L Sepulveda; V Nigam; F Charron; M Nemer; R J Schwartz
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

Authors:  Hyun Kook; John J Lepore; Aaron D Gitler; Min Min Lu; Wendy Wing-Man Yung; Joel Mackay; Rong Zhou; Victor Ferrari; Peter Gruber; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.

Authors:  Stephane Heymans; Blanche Schroen; Pieter Vermeersch; Hendrik Milting; Fangye Gao; Astrid Kassner; Hilde Gillijns; Paul Herijgers; Willem Flameng; Peter Carmeliet; Frans Van de Werf; Yigal M Pinto; Stefan Janssens
Journal:  Circulation       Date:  2005-08-15       Impact factor: 29.690

Review 8.  Heart failure therapy at a crossroad: are there limits to the neurohormonal model?

Authors:  Mandeep R Mehra; Patricia A Uber; Gary S Francis
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

Review 9.  Molecular mechanism of cardiac cellular hypertrophy by mechanical stress.

Authors:  T Yamazaki; I Komuro; Y Yazaki
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

10.  Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy.

Authors:  J J Schier; R S Adelstein
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  6 in total

1.  Prior exposure to imatinib does not impact outcome of allogeneic hematopoietic transplantation for chronic myeloid leukemia patients: a single-center experience in china.

Authors:  Kefeng Shen; Qifa Liu; Jing Sun; Qianli Jiang; Yanyan Ye; Hao Huang; Fanyi Meng; Yongjun Zhou; Mo Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Role of double knockdown of tPA and MMP-9 on regulating the left ventricular function and remodeling followed by transverse aortic constriction-induced hypertrophic cardiomyopathy in mice.

Authors:  Pei-Hsun Sung; Sarah Chua; Kuan-Hung Chen; Cheuk-Kwan Sun; Yi-Chen Li; Chi-Ruei Huang; Chi-Wen Luo; Han-Tan Chai; Hung-I Lu; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression.

Authors:  Koichiro Kuwahara; Hideyuki Kinoshita; Yoshihiro Kuwabara; Yasuaki Nakagawa; Satoru Usami; Takeya Minami; Yuko Yamada; Masataka Fujiwara; Kazuwa Nakao
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

4.  Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls.

Authors:  Abayomi O Bamgboje; Muheez A Durosinmi; Tuoyo O Mene-Afejuku; Micheal O Fagbayimu; Olusola Fajobi; Michael O Balogun
Journal:  Vasc Health Risk Manag       Date:  2022-02-15

Review 5.  Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction.

Authors:  Judith Bernal-Ramirez; Magda C Díaz-Vesga; Matias Talamilla; Andrea Méndez; Clara Quiroga; Javier A Garza-Cervantes; Anay Lázaro-Alfaro; Carlos Jerjes-Sanchez; Mauricio Henríquez; Gerardo García-Rivas; Zully Pedrozo
Journal:  Oxid Med Cell Longev       Date:  2021-08-28       Impact factor: 6.543

Review 6.  Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib.

Authors:  Stefania Gorini; Antonella De Angelis; Liberato Berrino; Natalia Malara; Giuseppe Rosano; Elisabetta Ferraro
Journal:  Oxid Med Cell Longev       Date:  2018-03-18       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.